Bunamiodyl

CHEMBL2110636 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
639.0 g/mol
LogP
4.6
Phase
4

An iodinated contrast agent historically used for cholecystography, a type of X-ray imaging of the gallbladder. It was administered orally and concentrated in the bile to visualize the gallbladder and bile ducts. It has been replaced by ultrasound and other modern imaging techniques.

Moleküler Ağırlık

639,0100 g/mol

LogP

4,60

TPSA

66,40 Ų

Lipinski RO5

Geçer

Etki Mekanizması

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mekanizma

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCC(=O)Nc1c(I)cc(I)c(/C=C(\CC)C(=O)O)c1I

InChI

InChI=1S/C15H16I3NO3/c1-3-5-12(20)19-14-11(17)7-10(16)9(13(14)18)6-8(4-2)15(21)22/h6-7H,3-5H2,1-2H3,(H,19,20)(H,21,22)/b8-6+

Molecular Formula

C15H16I3NO3

HBD / HBA

2 / 3

Döndürülebilir Bağlar

6

Ağır Atomlar

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

An iodinated contrast agent historically used for cholecystography, a type of X-ray imaging of the gallbladder. It was administered orally and concentrated in the bile to visualize the gallbladder and bile ducts. It has been replaced by ultrasound and other modern imaging techniques.

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

Yes, Bunamiodyl is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2110636. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 6436657. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.